Report cover image

Middle East Syphilis Testing Market Size, Share & Trends Analysis Report By Technology (Molecular Diagnostics, Immunoassay), By Location of Testing (Laboratory Testing, Public Health Labs), By Region, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Oct 09, 2025
Length 236 Pages
SKU # GV20575021

Description

Middle East Syphilis Testing Market Summary

The Middle East syphilis testing market size was estimated at USD 21.25 million in 2024 and is projected to reach USD 55.01 million by 2033, growing at a CAGR of 11.47% from 2025 to 2033. Growing public health awareness and government-led initiatives are driving demand for syphilis diagnostics across the Middle East. The region has placed infectious disease control at the center of its healthcare priorities, with syphilis screening integrated into antenatal care, premarital testing, and expatriate health checks in many Gulf countries.

Rising mobility of populations, large expatriate communities, and cross-border labor flows have made early detection and prevention programs essential. Concurrently, healthcare providers in the region are rapidly adopting advanced diagnostic technologies, including point-of-care rapid tests and laboratory-based immunoassays, to strengthen surveillance and ensure timely treatment.

Saudi Arabia’s health system emphasizes centralized lab capacity and antenatal screening within public hospitals; demand for high-quality immunoassays and molecular confirmatory testing remains strong. Simultaneously, Gulf Cooperation Council (GCC) initiatives and private hospitals are open to rapid POC solutions for screening travelers, migrant worker clinics, and perinatal care. Market entry requires regulatory clearance, adherence to national procurement, and partnerships with major hospital groups. Opportunities exist for accredited dual HIV/syphilis rapid tests that meet Saudi regulatory standards and can be deployed in maternal health and occupational-health screening programs.

The prevalence of syphilis in the Middle East and North Africa (MENA) is higher than anticipated given regional norms, but it is comparable to global levels. According to a 2024 study, the prevalence was 0.48% in the general population overall, but significantly higher rates were found in high-risk groups such as female sex workers (FSW) and men who have sex with men (MSM). Although prevalence is decreasing, it is not doing so quickly enough to reach international goals. Testing includes techniques like rapid plasma reagin (RPR) and Treponema pallidum-specific tests to identify current and previous infections.

Syphilis testing in the UAE utilizes Rapid Plasma Reagin (RPR) and Treponema pallidum Hemagglutination (TPHA) tests, and a recent study in 2016 showed a 0.51% prevalence among expatriate workers undergoing health checks. Another study in 2021 found a 0.45% syphilis seropositivity rate among individuals screened in a tertiary hospital, with higher rates among non-Saudi expatriates compared to Saudis.

Middle East Syphilis Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East syphilis testing market based on technology, location of testing, and region:
  • Technology Outlook (USD Million, 2021 - 2033)
  • Molecular Diagnostics
  • Immunoassay
  • Others
  • Location of Testing Outlook (USD Million, 2021 - 2033)
  • Laboratory Testing
  • Commercial/Private labs
  • Public Health Labs
  • Point of Care Testing
  • Regional Outlook (USD Million, 2021 - 2033)
  • Middle East
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

236 Pages
Chapter 1. Middle East Syphilis Testing Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Technology Segment
1.1.1.2. Location of Testing Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Middle East Syphilis Testing Market: Executive Summary
2.1. Market Snapshot
2.2. Technology and Location of Testing Snapshot
2.3. Cancer Type and Function Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Middle East Syphilis Testing Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.5. Market Restraint Analysis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Middle East Syphilis Testing Market: Technology Estimates & Trend Analysis
4.1. Middle East Syphilis Testing Market: Technology Movement Analysis
4.2. Molecular Diagnostics
4.2.1. Molecular Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
4.3. Immunoassay
4.3.1. Immunoassay Market Estimates And Forecasts, 2021 - 2033 (USD Million)
4.4. Others
4.4.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Syphilis Testing Market: Location of Testing Estimates & Trend Analysis
5.1. Middle East Syphilis Testing Market: Location of Testing Movement Analysis
5.2. Laboratory Testing
5.2.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.2.2. Commercial/Private Labs
5.2.2.1. Commercial/Private Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.2.3. Public Health Labs
5.2.3.1. Public Health Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Point of Care Testing
5.3.1. Point of Care Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Syphilis Testing Market: Regional Business Analysis
6.1. Regional Market Snapshot
6.1.1. Middle East Syphilis Testing Market, 2021 - 2033 (USD Million)
6.1.2. SAUDI ARABIA
6.1.2.1. Saudi Arabia Syphilis Testing Market, 2021 - 2033 (USD Million)
6.1.2.2. Key Country Dynamics
6.1.2.3. Regulatory Framework
6.1.2.4. Reimbursement Scenario
6.1.2.5. Competitive Scenario
6.1.3. UAE
6.1.3.1. UAE Middle East Syphilis Testing Market, 2021 - 2033 (USD Million)
6.1.3.2. Key Country Dynamics
6.1.3.3. Regulatory Framework
6.1.3.4. Reimbursement Scenario
6.1.3.5. Competitive Scenario
6.1.4. KUWAIT
6.1.4.1. Kuwait Middle East Syphilis Testing Market, 2021 - 2033 (USD Million)
6.1.4.2. Key Country Dynamics
6.1.4.3. Regulatory Framework
6.1.4.4. Reimbursement Scenario
6.1.4.5. Competitive Scenario
6.1.5. Oman
6.1.5.1. Kuwait Middle East Syphilis Testing Market, 2021 - 2033 (USD Million)
6.1.5.2. Key Country Dynamics
6.1.5.3. Regulatory Framework
6.1.5.4. Reimbursement Scenario
6.1.5.5. Competitive Scenario
6.1.6. Qatar
6.1.6.1. Kuwait Middle East Syphilis Testing Market, 2021 - 2033 (USD Million)
6.1.6.2. Key Country Dynamics
6.1.6.3. Regulatory Framework
6.1.6.4. Reimbursement Scenario
6.1.6.5. Competitive Scenario
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. NEW PRODUCT LAUNCH
7.2.2. PARTNERSHIPS
7.2.3. ACQUISITION
7.2.4. COLLABORATION
7.2.5. FUNDING
7.3. Key Company Market Share Analysis, 2024
7.4. Company Heat Map Analysis
7.5. Company Profiles
7.5.1. ABBOTT LABORATORIES
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. BIO-RAD LABORATORIES, INC.
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. F. HOFFMANN-LA ROCHE LTD
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. SIEMENS HEALTHINEERS AG
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. DANAHER CORPORATION (BECKMAN COULTER)
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.6. BIOMÉRIEUX SA
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. THERMO FISHER SCIENTIFIC, INC.
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. ORASURE TECHNOLOGIES, INC.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. CHEMBIO DIAGNOSTICS, INC.
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. SD BIOSENSOR, INC.
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us